Cargando…

Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells

Bone morphogenetic proteins (BMPs) have been widely used as treatment for bone repair. However, clinical trials on fracture repair have challenged the effectiveness of BMPs and suggested that delivery of multipotent bone marrow stromal cells (BMSCs) might be beneficial. During bone remodeling and bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Eun, Seon, Jong Keun, Kang, Ju Yeon, Yoon, Taek Rim, Lee, Jun Sik, Kim, Hyung Keun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526923/
https://www.ncbi.nlm.nih.gov/pubmed/34692657
http://dx.doi.org/10.3389/fbioe.2021.734483
_version_ 1784585968013017088
author Kim, Mi Eun
Seon, Jong Keun
Kang, Ju Yeon
Yoon, Taek Rim
Lee, Jun Sik
Kim, Hyung Keun
author_facet Kim, Mi Eun
Seon, Jong Keun
Kang, Ju Yeon
Yoon, Taek Rim
Lee, Jun Sik
Kim, Hyung Keun
author_sort Kim, Mi Eun
collection PubMed
description Bone morphogenetic proteins (BMPs) have been widely used as treatment for bone repair. However, clinical trials on fracture repair have challenged the effectiveness of BMPs and suggested that delivery of multipotent bone marrow stromal cells (BMSCs) might be beneficial. During bone remodeling and bone fracture repair, multipotent BMSCs differentiate into osteoblasts or chondrocytes to stimulate bone formation and regeneration. Stem cell-based therapies provide a promising approach for bone formation. Extensive research has attempted to develop adjuvants as specific stimulators of bone formation for therapeutic use in patients with bone resorption. We previously reported for the first time bone-forming peptides (BFPs) that induce osteogenesis and bone formation. BFPs are also a promising osteogenic factor for prompting bone regeneration and formation. Thus, the aim of the present study was to investigate the underlying mechanism of a new BFP-4 (FFKATEVHFRSIRST) in osteogenic differentiation and bone formation. This study reports that BFP-4 induces stronger osteogenic differentiation of BMSCs than BMP-7. BFP-4 also induces ALP activity, calcium concentration, and osteogenic factors (Runx2 and osteocalcin) in a dose dependent manner in BMSCs. Therefore, these results indicate that BFP-4 can induce osteogenic differentiation and bone formation. Thus, treatment of multipotent BMSCs with BFP-4 enhanced osteoblastic differentiation and displayed greater bone-forming ability than BMP-7 treatment. These results suggest that BFP-4-stimulated cell therapy may be an efficient and cost-effective complement to BMP-7-based clinical therapy for bone regeneration and formation.
format Online
Article
Text
id pubmed-8526923
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85269232021-10-21 Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells Kim, Mi Eun Seon, Jong Keun Kang, Ju Yeon Yoon, Taek Rim Lee, Jun Sik Kim, Hyung Keun Front Bioeng Biotechnol Bioengineering and Biotechnology Bone morphogenetic proteins (BMPs) have been widely used as treatment for bone repair. However, clinical trials on fracture repair have challenged the effectiveness of BMPs and suggested that delivery of multipotent bone marrow stromal cells (BMSCs) might be beneficial. During bone remodeling and bone fracture repair, multipotent BMSCs differentiate into osteoblasts or chondrocytes to stimulate bone formation and regeneration. Stem cell-based therapies provide a promising approach for bone formation. Extensive research has attempted to develop adjuvants as specific stimulators of bone formation for therapeutic use in patients with bone resorption. We previously reported for the first time bone-forming peptides (BFPs) that induce osteogenesis and bone formation. BFPs are also a promising osteogenic factor for prompting bone regeneration and formation. Thus, the aim of the present study was to investigate the underlying mechanism of a new BFP-4 (FFKATEVHFRSIRST) in osteogenic differentiation and bone formation. This study reports that BFP-4 induces stronger osteogenic differentiation of BMSCs than BMP-7. BFP-4 also induces ALP activity, calcium concentration, and osteogenic factors (Runx2 and osteocalcin) in a dose dependent manner in BMSCs. Therefore, these results indicate that BFP-4 can induce osteogenic differentiation and bone formation. Thus, treatment of multipotent BMSCs with BFP-4 enhanced osteoblastic differentiation and displayed greater bone-forming ability than BMP-7 treatment. These results suggest that BFP-4-stimulated cell therapy may be an efficient and cost-effective complement to BMP-7-based clinical therapy for bone regeneration and formation. Frontiers Media S.A. 2021-10-06 /pmc/articles/PMC8526923/ /pubmed/34692657 http://dx.doi.org/10.3389/fbioe.2021.734483 Text en Copyright © 2021 Kim, Seon, Kang, Yoon, Lee and Kim. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Kim, Mi Eun
Seon, Jong Keun
Kang, Ju Yeon
Yoon, Taek Rim
Lee, Jun Sik
Kim, Hyung Keun
Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells
title Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells
title_full Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells
title_fullStr Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells
title_full_unstemmed Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells
title_short Bone-Forming Peptide-4 Induces Osteogenic Differentiation and VEGF Expression on Multipotent Bone Marrow Stromal Cells
title_sort bone-forming peptide-4 induces osteogenic differentiation and vegf expression on multipotent bone marrow stromal cells
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526923/
https://www.ncbi.nlm.nih.gov/pubmed/34692657
http://dx.doi.org/10.3389/fbioe.2021.734483
work_keys_str_mv AT kimmieun boneformingpeptide4inducesosteogenicdifferentiationandvegfexpressiononmultipotentbonemarrowstromalcells
AT seonjongkeun boneformingpeptide4inducesosteogenicdifferentiationandvegfexpressiononmultipotentbonemarrowstromalcells
AT kangjuyeon boneformingpeptide4inducesosteogenicdifferentiationandvegfexpressiononmultipotentbonemarrowstromalcells
AT yoontaekrim boneformingpeptide4inducesosteogenicdifferentiationandvegfexpressiononmultipotentbonemarrowstromalcells
AT leejunsik boneformingpeptide4inducesosteogenicdifferentiationandvegfexpressiononmultipotentbonemarrowstromalcells
AT kimhyungkeun boneformingpeptide4inducesosteogenicdifferentiationandvegfexpressiononmultipotentbonemarrowstromalcells